Please login to the form below
CROS NT appoints Andrew MacGarvey to lead new UK office
Contract research organisation's new facility will be based in Milton Keynes
Italian contract research organisation CROS NT has expanded into the UK and appointed Andrew MacGarvey to lead operations from its new facility in Milton Keynes.
MacGarvey has over 15 years' experience within the pharmaceutical sector and as CROS NT's new vice president of UK and USA operations he will be tasked with growing ties with the contract research organisation's UK-based customers.
MacGarvey previously held senior management and director roles at multiple contract research organisation (CROs) in Europe and the US.
"I have followed the activities of CROS NT for some time," MacGarvey said. "I am excited by the opportunity to help with the growth of the business. CROS NT are focused on customer care, something that is very important to me. I will be bringing their great service to the UK and ultimately the US."
Verona-headquartered CROS NT's new UK base joins its existing facilities in Italy and Augsburg, Germany.
Subscribe to our email news alerts
Featured jobs
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Takeda and Daiichi Sankyo collaborate to create wearable device
- Scientists discover new approach to treat brain tumours
- New Pfizer initiative, ‘An Accord for a Healthier World’, launched to improve global health equity
- Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Dermavant’s Vtama receives FDA approval for plaque psoriasis
- Phase 3 trial initiated to evaluate AZ's Saphnelo in lupus nephritis
- Dermavant’s Vtama receives FDA approval for plaque psoriasis
- EORTC and Pierre Fabre launch phase 3 trial for melanoma
- Using ethnography to uncover the authentic patient experience
- 11 London: first UK healthcare agency to be awarded B Corp status
- Improving Drug Access with Data Analytics
No results were found
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
- Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
- What does the future hold for clinical trial recruitment?
- The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
- When is an agency not an agency?
- The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
